Combinature appoints Harald Labischinski as Chief Executive Officer
Combinature Biopharm AG announced that the company's Supervisory Board has appointed Prof. Dr. Harald Labischinski as a member of the Management Board and Chief Executive Officer, with effect as of 15 April 2005.
Harald Labischinski is an internationally recognised expert in the development of antibiotics, who worked for Bayer Health Care AG for the past 12 years, including several years as head of anti-infectives and antibiotics research. In addition, he was responsible for early and late stage portfolio management in the anti-infectives business area including in- and out-licensing activities and external collaborations. Before that, Harald Labischinski spent more than 10 years in a managerial position at the Robert Koch Institute for Infection Research in Berlin. He also has excellent connections to the world of academic research, for example as the current president of the German Association for General and Applied Microbiology (VAAM). Dr. Rolf Zettl, co-founder of the company and CEO since November 2000, will remain on the company's Management Board as Chief Business Officer.
Other news from the department people
